Interpret umbilical cord blood gases and fetal acid-base status

In one line

A paired umbilical artery and vein gas is the only objective, contemporaneous measure of how the fetus tolerated the last minutes of labour; the number that matters is not the pH alone but the metabolic component, because respiratory acidosis is transient and self-correcting while a metabolic acidaemia (umbilical artery pH <7.00 with a base deficit ≥12.0 mmol/L) is the threshold that links an intrapartum event to a real risk of encephalopathy.

Mechanism & pathophysiology

The placenta is the fetal lung, kidney and gut, and the cord gas is a snapshot of that organ failing or coping. Gas exchange across the intervillous space is flow-limited for oxygen and diffusion-efficient for carbon dioxide, so the first thing to fail when uteroplacental perfusion drops — a tachysystolic uterus, a tightening cord, a sentinel abruption — is CO₂ clearance. Carbon dioxide accumulates in fetal blood within seconds to minutes, carbonic acid forms, and the pH falls. This is respiratory acidosis: a high pCO₂, a pH that has dropped, but a normal or near-normal base excess because no fixed acid has been generated. It is the acidosis of a brief, recoverable insult — a single prolonged deceleration, a short cord compression — and it reverses within minutes of the first few effective neonatal breaths, because the newborn lung simply blows the CO₂ off.

What converts a recoverable picture into a dangerous one is oxygen debt. When delivery of oxygen falls below the fetus's metabolic demand, tissues switch from aerobic metabolism to anaerobic glycolysis. Pyruvate is shunted to lactate rather than entering the Krebs cycle, and lactic acid — a fixed, non-volatile acid — accumulates. This is metabolic acidaemia: the base deficit climbs (bicarbonate and the other buffers are consumed neutralising the new acid), lactate rises, and pH falls in a way the lung cannot fix by ventilating, because the problem is acid, not CO₂. The base deficit is the quantitative read-out of how much buffer has been spent, and therefore of the depth and duration of the anaerobic period. A fetus tolerates respiratory acidosis indefinitely; it tolerates progressive metabolic acidaemia for a finite time before cellular energy failure, membrane depolarisation, calcium influx and the excitotoxic cascade that underlies hypoxic-ischaemic brain injury begin. That is why the metabolic component, not the pH headline, carries the prognosis.

Fetal blood is comparatively well buffered — fetal haemoglobin, bicarbonate and the placental capacity to clear CO₂ to the maternal circulation all blunt the pH fall for a given acid load — which is precisely why a frankly low base deficit signifies a substantial insult: the buffers have been overwhelmed. Two buffer compartments matter, and conflating them is a classic interpretive error. The base deficit of the blood (BDblood) includes the contribution of haemoglobin as a buffer; the base deficit of the extracellular fluid (BDecf, sometimes BDfluid) models the larger, more slowly equilibrating extracellular space and is the better reflection of the true tissue metabolic burden. Analysers calculate base deficit by an algorithm rather than measuring it, so two machines can return different base-deficit values from the same pH and pCO₂ — which is part of why some authorities prefer lactate, a directly measured quantity, as the metabolic marker. A mixed acidosis (high pCO₂ and a large base deficit) is the common real-world picture of an evolving insult caught partway through: an early respiratory phase that perfusion failure has driven on into anaerobic metabolism. Reading the gas is therefore an exercise in apportioning the pH fall between its volatile (respiratory, benign) and fixed (metabolic, dangerous) causes.

The timescale separates the two cleanly. A respiratory acidosis builds over seconds to a few minutes and resolves over minutes once ventilation is restored, so a cord gas drawn after a single late or prolonged deceleration that recovered will often show a respiratory pattern that has already half-corrected. A metabolic acidaemia builds over the order of tens of minutes of sustained oxygen debt and resolves over hours, as the liver and kidney clear lactate and regenerate bicarbonate; it therefore lags the insult and persists past it, which is why a frankly metabolic cord gas implies a sustained period of compromised oxygen delivery rather than a single brief event. The depth of the base deficit is thus a crude integral of how long, and how severely, anaerobic metabolism ran — and that integral, not the instantaneous pH, is what tracks the risk of cellular energy failure in the brain.

Buffering is what determines how far the pH moves for a given acid load, and it is worth being precise about the chemistry because the base deficit is simply the quantification of buffer consumed. The dominant open buffer system is bicarbonate–carbonic acid, which the placenta keeps "open" by continuously exporting CO₂ to the maternal circulation; haemoglobin (largely fetal haemoglobin at term) is the major non-bicarbonate buffer, with smaller contributions from plasma proteins and phosphate. When fixed acid (lactic acid) is generated, hydrogen ions are mopped up by bicarbonate — consuming it and generating CO₂, which a functioning placenta then clears — and by haemoglobin. The base deficit measures exactly this depletion: it is the amount of base that would have to be added to return the blood to a normal pH at a normal pCO₂, and it rises as the metabolic insult consumes buffer. This is why the placenta's dual role is central: as the gas-exchange organ it both clears the volatile acid (CO₂) directly and regenerates the capacity to buffer the fixed acid (by removing the CO₂ produced when bicarbonate neutralises lactate). When placental perfusion fails, both functions fail together — CO₂ accumulates (the respiratory component) and buffer is consumed without being regenerated (the metabolic component) — which is the chemistry behind the common mixed picture.

The two cord vessels carry opposite information. The umbilical vein brings oxygenated, placentally-buffered blood to the fetus and reflects maternal–placental status; the umbilical arteries carry deoxygenated blood from the fetus back to the placenta and reflect the fetal tissues' own acid-base state. The artery is therefore always the more acidic, higher-pCO₂, higher-lactate vessel — and that physiological gradient is the basis of validating a sample, developed below.

Assessment

The discipline of cord-gas interpretation is sampling correctly, confirming the sample is genuine, and then partitioning the acidosis.

• Take a paired sample, immediately, into pre-heparinised syringes. Double-clamp a 10–20 cm segment of cord at delivery (before the first breath alters the picture) and draw from the umbilical artery and vein separately. The double-clamped segment is the safeguard against time-dependent drift.
• Validate the pair before you trust any number. The artery must be more acidic than the vein. A veno-arterial pH difference (ΔpH = umbilical vein pH − umbilical artery pH) of about 0.08 is the population mean, and a ΔpH below ~0.02 means you have not sampled two different vessels — almost always two venous samples — so a reassuringly "normal" artery may be a mislabelled vein hiding a true arterial acidaemia. A near-zero ΔpH (or a difference in pCO₂ <0.5 kPa between the two) invalidates the pair; report it as such rather than reassuring the team on a sample that proves nothing. This single check is the most common reason an apparently normal gas is wrong.
• Reference ranges (term, uncomplicated delivery). For the umbilical artery: median pH ~7.27 (5th–95th centile ~7.12–7.35), pCO₂ ~7.3 kPa (~55 mmHg), base excess ~−3 mmol/L (down to about −9), lactate ~3.7 mmol/L. For the umbilical vein: median pH ~7.35 (~7.23–7.44), pCO₂ ~5.4 kPa (~40 mmHg), base excess ~−3 mmol/L, lactate ~1 mmol/L. The statistically defined lower limit of normal arterial pH (mean − 2 SD) sits around 7.10 — so a pH in the low 7.1s is at the edge of the reference range, not yet the danger zone.
• The thresholds that carry weight. Acidaemia by pH is graded: an arterial pH <7.20 is found in roughly 7–9% of births, <7.10 in 1–3%, and <7.00 in only about 0.26–1.3% — the rarity of pH <7.00 is exactly why it features in causation criteria. The clinically significant figure is metabolic acidaemia: umbilical artery pH <7.00 together with a base deficit ≥12.0 mmol/L. The base deficit dose-response is steep: moderate or severe newborn complications occur in about 10% at a base deficit of 12–16 mmol/L and ~40% above 16 mmol/L.
• Partition the acidosis from the same gas. A low pH with a high pCO₂ and a near-normal base deficit is respiratory — transient, expect rapid correction, reassure. A low pH with a normal-ish pCO₂ but a base deficit ≥12 and a high lactate is metabolic — the dangerous pattern. A low pH with both abnormal is mixed — an evolving insult. Always read the base deficit and lactate, never the pH in isolation; a registrar who reports "pH 7.05, baby's acidotic" without saying which kind has not interpreted the gas.

Why the gas is read against the baby, not in isolation

A cord gas is a laboratory number that means little without the clinical narrative. A low arterial pH in a vigorous, pink, crying baby with normal Apgars usually reflects a recoverable respiratory or modest metabolic dip; the same number in a flat, hypotonic, non-responsive baby who needed resuscitation points to a metabolic acidaemia of consequence. The gas correlates with — but does not by itself diagnose — neonatal compromise, and the intrapartum CTG provides the temporal context: a gas should be read alongside the trace that preceded it, because a metabolic acidaemia after a long bradycardia tells a coherent story, whereas an unexpected acidaemia after a reassuring trace should prompt a search for a pre-analytical artefact or a sentinel event the monitoring missed.

The correlations are loose, and stating them precisely matters. The cord pH correlates only modestly with the Apgar score, because the Apgar is depressed by many non-acidaemic causes — prematurity, maternal opioids and anaesthesia, sepsis, congenital neuromuscular disease — so a flat baby with a normal arterial gas is pointing away from an intrapartum acidaemic mechanism and towards one of those alternatives, which is a useful diagnostic redirection rather than a contradiction to be explained away. Equally, most babies with a low cord pH are neurologically normal: the positive predictive value of a metabolic acidaemia for encephalopathy is modest, even though its negative predictive value is high (a genuinely normal arterial gas makes a purely intrapartum hypoxic injury very unlikely). The asymmetry is the clinically and medico-legally important property — the gas is far better at exonerating the intrapartum period than at convicting it. The link to outcome runs through the metabolic component: the umbilical-artery pH <7.0 / base deficit ≥12 threshold is one of the neonatal-sign criteria used to attribute neonatal encephalopathy and later cerebral palsy to an acute intrapartum event — but the gas is one criterion among several, never a verdict on its own.

Management

Cord-gas "management" is sampling policy, the pre-analytical handling that protects the result, and what an abnormal result triggers — framed immediate → ongoing → long-term.

Immediate — sample, validate, act on the baby.

• Sample at every birth where the fetal condition was in question: all caesarean and instrumental births, any birth preceded by an abnormal or pathological CTG, suspected abruption or sentinel event, meconium, shoulder dystocia, multiple pregnancy, and any depressed or unexpectedly flat baby. The threshold to sample should be low, because the cohort in whom the gas matters most is precisely the one where it was not anticipated.
• The pre-analytical chain is the result. A double-clamped cord segment is stable at room temperature for roughly 60 minutes, and a sample in a capped heparinised syringe for about the same — but analyse within ~30 minutes for accuracy. Exclude air bubbles before capping (a bubble equilibrates the sample towards room air: pO₂ rises, pCO₂ falls, pH drifts up — falsely reassuring). Avoid heparin dilution: too much liquid heparin dilutes bicarbonate and lowers pH and base excess artefactually — use a minimal-volume balanced-heparin syringe. And do not delay clamping if a true birth gas is wanted: the "hidden acidosis" phenomenon means that even ~45 seconds of delayed clamping lets pH and base excess fall and pCO₂/lactate rise, so a gas drawn after delayed clamping is a slightly different, later measurement (this is increasingly relevant now that delayed cord clamping is routine — document the clamping time).
• Act on the metabolic acidaemia, not the gas itself. The gas does not change neonatal resuscitation in the moment — that is driven by the baby's tone, breathing and heart rate — but a confirmed metabolic acidaemia (pH <7.0, base deficit ≥12) at term flags an infant in whom evolving encephalopathy must be actively sought, because that infant is a candidate for therapeutic hypothermia if moderate or severe encephalopathy declares within the first hours. The gas helps select for cooling; it does not replace the neurological examination (and, where available, amplitude-integrated EEG) that confirms it. A cord pH ≤7.0 or base deficit ≥12, or a 10-minute Apgar ≤5, or a continued need for ventilation at 10 minutes, are the entry gates the cooling trials used to define the at-risk newborn — so the cord gas is one of the first pieces of data that opens or closes the cooling pathway, and it must be drawn, validated and read promptly for that reason, not filed for later audit.

Ongoing — record, correlate, escalate. Record both vessels' full values (pH, pCO₂, pO₂, base excess/deficit, lactate) and the ΔpH validation in the notes, alongside the Apgars and the resuscitation. Correlate with the CTG and the events of labour. Escalate the metabolically acidaemic term infant to neonatal review for serial encephalopathy assessment within the therapeutic-hypothermia window.

Long-term — the medico-legal record. A correctly sampled, validated paired gas is the single most powerful piece of contemporaneous evidence in a future cerebral-palsy claim. A normal arterial gas (pH and base deficit within range) is strong objective evidence against an intrapartum hypoxic cause of any later neurological injury — it shifts the timing of the insult away from the minutes before birth. Conversely, the absence of a gas where one should have been taken is itself a criticism, and a single unvalidated venous "normal" is worse than no gas, because it offers false reassurance that does not survive expert scrutiny. The discipline of taking, validating and documenting the pair — both vessels' full panel, the ΔpH check, the clamping-to-analysis interval, alongside the Apgars and the resuscitation record — is therefore as much risk management as it is clinical assessment. This is not abstract in South Africa: medico-legal claims against the state for alleged intrapartum hypoxic injury run to many billions of rand in contingent liability, the great majority hinging on whether the intrapartum period can be implicated, and a properly documented normal cord gas is frequently the decisive contemporaneous evidence that the timing does not fit an intrapartum cause.

The universal-versus-selective debate

Whether to sample every birth or only high-risk births is unsettled, and the honest answer is resource-dependent. The case for universal paired sampling is that the babies who most need a gas — the unexpected flat baby after a reassuring trace — are by definition unpredictable, and a unit that samples everyone never misses the index case, accumulates its own reference data, and audits intrapartum care objectively. The case for selective sampling is cost, analyser capacity and the very low yield of sampling the entirely uncomplicated vigorous baby. NICE, reflecting limited evidence, declines to mandate universal sampling; UK practice (RCOG/RCM-aligned) is selective — caesarean and instrumental births for fetal compromise, abnormal FHR, and depressed neonates. In a high-volume SA labour ward with a single shared analyser, blanket universal sampling is often simply undeliverable, and a robust selective policy — sampled reliably in every caesarean, instrumental and abnormal-CTG birth, with a low threshold to extend it — is the defensible standard.

Guidelines compared

The substantive disagreement is narrow: every body uses essentially the same metabolic-acidaemia numbers (pH <7.0, base deficit ≥12). They diverge on who to sample — selective everywhere in practice, with no high-quality evidence yet to settle universal-versus-selective — and on how the gas is framed: ACOG/AAP treat it as a causation criterion, the UK bodies as a quality and risk-management measurement. The recent shift worth flagging is conceptual rather than numerical: the ACOG/AAP 2014 second edition abandoned the rigid first-edition requirement that all "essential criteria" (including a pH <7.0 / base deficit ≥12 gas) be met before an intrapartum cause could be considered, replacing it with a more nuanced weighing of neonatal signs and contributing type/timing factors — which means a gas above the threshold no longer excludes an intrapartum contribution as cleanly as the old criteria implied, and a gas below it is necessary but not sufficient to prove one.

The evidence & the controversy

The central interpretive controversy is how much prognostic weight the base deficit truly carries once pH is known. The threshold of pH <7.0 with base deficit ≥12 is robust as a population marker of metabolic acidaemia, and the base-deficit dose-response (≈10% complications at 12–16, ≈40% above 16) is real. But within the already-acidaemic group, there is a respectable argument that the metabolic component adds little independent prediction once the pH is accounted for — that the pH already encodes most of the prognostic information and the base deficit is partly redundant. This matters in the witness box: a defence that leans entirely on a base deficit of 11.8 to argue "below threshold, therefore not hypoxic" overreaches, because these thresholds are statistical conveniences on a continuous biological variable, not biological cliffs. The correct framing is that the metabolic-acidaemia threshold identifies a population at materially raised risk, while the individual baby's outcome is determined by the depth, duration and the brain's own resilience — which is why the gas is one criterion among several, not the answer.

A second live issue is lactate. Point-of-care lactate analysers are cheap, fast and need a tiny sample, and in the intrapartum setting the Wiberg-Itzel multicentre RCT showed scalp lactate performed equivalently to scalp pH in preventing birth acidaemia (metabolic acidaemia 3.2% vs 3.6%, no significant difference). The same logic applies to cord blood: a cord lactate is a faster, more robust surrogate for the metabolic burden than a calculated base deficit (which depends on the algorithm the analyser uses and is more sensitive to pre-analytical error), and for a resource-limited SA unit a reliable cord lactate may be more deliverable than a full blood-gas panel. The caveat is that lactate reference ranges and thresholds are analyser-specific and less standardised than pH, so a unit must use its own device's cut-offs rather than importing numbers from a paper.

The current-practice thread that has changed the gas itself is delayed cord clamping. Delaying clamping by 60 seconds or more is standard for the neonatal benefits, so the "birth gas" is no longer drawn at the instant of delivery, and the hidden-acidosis drift means the documented gas is a slightly later, marginally more acidotic measurement than the historical immediate-clamp value. This is not a reason to abandon delayed clamping; it is a reason to record the clamping-to-sampling interval so the gas is interpreted in context, and a reason not to over-read a mildly low pH drawn after a deliberately delayed clamp.

For the South African service the controversy is more concrete than academic. The constraint is rarely the threshold and almost always the analyser: a single blood-gas machine shared across a busy labour ward, a downtime when cartridges run out, a district hospital with no analyser at all that must rely on the regional referral centre's. Three pragmatic responses follow. First, a selective policy executed reliably beats a universal policy executed erratically — sample every caesarean, instrumental and abnormal-CTG birth properly rather than aspire to sample everyone and achieve it for no one. Second, a point-of-care lactate strip, which needs a tiny sample and no benchtop gas analyser, is often the most deliverable objective metabolic marker where a full panel is impractical, accepting that the unit must validate its own device's cut-offs. Third, where no analyser is reachable at all, the discipline of double-clamping and storing a labelled cord segment preserves the option of a delayed gas (stable ~60 minutes) and, failing that, makes the contemporaneous documentation of cord appearance, Apgars, resuscitation and CTG the medico-legal record instead — because in the SA litigation environment the cost of not having an objective account of the intrapartum period is measured in claims, not just in clinical uncertainty. None of this is captured by the international threshold debate, which assumes the gas was always obtainable.

Landmark trials & key evidence

A worked figure makes the validation rule concrete: the population mean veno-arterial gradient is ~0.08, so a "paired" gas reading UV pH 7.30 and UA pH 7.29 has a ΔpH of 0.01 — below the ~0.02 floor — which means it is almost certainly two venous samples, and the genuinely acidotic artery (which might have read 7.05) was never drawn. The apparently reassuring "7.29" is then not reassuring at all; it is uninterpretable, and the correct report is "sampling not validated," not "normal."

Exam traps & red flags

• Reading the pH and ignoring the base deficit. "pH 7.05, acidotic" is incomplete — partition it. A pH 7.05 with a high pCO₂ and base deficit of 4 is a transient respiratory acidosis; the same pH with a base deficit of 14 is a metabolic acidaemia of consequence. Naming which acidosis is the answer.
• Trusting an unvalidated pair. If the artery is not more acidic than the vein (ΔpH below ~0.02), the sample is two veins, not an artery and a vein — a "normal" arterial pH may be a mislabelled vein masking a true acidaemia. Always check the gradient before reassuring.
• Air bubble in the syringe. A bubble drifts pO₂ up, pCO₂ down and pH up — a falsely reassuring gas. Exclude bubbles and cap before mixing.
• Heparin dilution. Excess liquid heparin dilutes bicarbonate and falsely lowers pH and base excess — a falsely alarming gas. Use minimal balanced-heparin syringes.
• Delay or the hidden-acidosis effect. A gas analysed hours late, or drawn after delayed clamping without noting the interval, is a different (more acidotic) measurement — document the clamping-to-analysis time.
• Treating the threshold as a cliff. pH <7.0 and base deficit ≥12 mark a population at raised risk on a continuous variable; a base deficit of 11.8 does not "exclude" an insult, and pH 6.99 is not a different baby from pH 7.01. Argue the trajectory and the clinical picture, not the decimal.
• Confusing respiratory and metabolic acidosis prognostically. A respiratory acidosis is benign and self-correcting; reporting it as if it carried the risk of a metabolic acidaemia over-treats and over-alarms.
• Failing to sample where it mattered. No gas at a caesarean/instrumental/abnormal-CTG birth is both a clinical and a medico-legal omission; the missing gas can never later exonerate intrapartum care.
• Over-reading a low pH in a vigorous baby, or under-reading a normal gas in a flat baby. The gas is interpreted against the baby and the trace, not alone — discordance should prompt a hunt for a pre-analytical artefact or a sentinel event, not a reflex conclusion.

Evidence anchors

• ACOG/AAP — Executive summary: Neonatal encephalopathy and neurologic outcome, 2nd ed, Obstet Gynecol 2014 (full report: Pediatrics 2014;133(5):e1482–e1488)
• ACOG Committee Opinion No. 348 — Umbilical cord blood gas and acid-base analysis, Obstet Gynecol 2006
• Olofsson P — Umbilical cord pH, blood gases, and lactate at birth: normal values, interpretation, and clinical utility, Am J Obstet Gynecol 2023
• Sundberg et al. — Veno-arterial pH differences (ΔpH) in 108,629 newborns, BMC Pregnancy Childbirth 2023
• Wiberg-Itzel et al. — pH vs lactate in fetal scalp blood, BMJ 2008
• Umbilical-cord blood gas analysis — reference ranges and pre-analytical handling (acutecaretesting.org)
• South Africa NDoH, Guidelines for Maternity Care in South Africa — blood-gas syringes as standard newborn-resuscitation equipment; tier-dependent analyser access; cord-gas documentation feeds PPIP / perinatal-mortality audit.
• NICE NG229 (Fetal monitoring in labour) and NG235 (Intrapartum care) — selective, intrapartum-concern-driven sampling; no current mandate for universal cord sampling.